IBDEI0AN ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14208,0)
 ;;=282.46^^87^774^49
 ;;^UTILITY(U,$J,358.3,14208,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14208,1,1,0)
 ;;=1^282.46
 ;;^UTILITY(U,$J,358.3,14208,1,8,0)
 ;;=8^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,14208,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,14209,0)
 ;;=282.47^^87^774^18
 ;;^UTILITY(U,$J,358.3,14209,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14209,1,1,0)
 ;;=1^282.47
 ;;^UTILITY(U,$J,358.3,14209,1,8,0)
 ;;=8^Hemoglobin E-beta Thalassemia
 ;;^UTILITY(U,$J,358.3,14209,2)
 ;;=^340498
 ;;^UTILITY(U,$J,358.3,14210,0)
 ;;=282.49^^87^774^38
 ;;^UTILITY(U,$J,358.3,14210,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14210,1,1,0)
 ;;=1^282.49
 ;;^UTILITY(U,$J,358.3,14210,1,8,0)
 ;;=8^Oth Thalassemia
 ;;^UTILITY(U,$J,358.3,14210,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,14211,0)
 ;;=282.5^^87^774^45
 ;;^UTILITY(U,$J,358.3,14211,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14211,1,1,0)
 ;;=1^282.5
 ;;^UTILITY(U,$J,358.3,14211,1,8,0)
 ;;=8^Sickle-cell Trait
 ;;^UTILITY(U,$J,358.3,14211,2)
 ;;=^110419
 ;;^UTILITY(U,$J,358.3,14212,0)
 ;;=282.60^^87^774^43
 ;;^UTILITY(U,$J,358.3,14212,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14212,1,1,0)
 ;;=1^282.60
 ;;^UTILITY(U,$J,358.3,14212,1,8,0)
 ;;=8^Sickle-cell Disease Unspec
 ;;^UTILITY(U,$J,358.3,14212,2)
 ;;=^330077
 ;;^UTILITY(U,$J,358.3,14213,0)
 ;;=282.62^^87^774^16
 ;;^UTILITY(U,$J,358.3,14213,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14213,1,1,0)
 ;;=1^282.62
 ;;^UTILITY(U,$J,358.3,14213,1,8,0)
 ;;=8^Hb-SS Disease w/ Crisis
 ;;^UTILITY(U,$J,358.3,14213,2)
 ;;=^330079
 ;;^UTILITY(U,$J,358.3,14214,0)
 ;;=282.61^^87^774^17
 ;;^UTILITY(U,$J,358.3,14214,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14214,1,1,0)
 ;;=1^282.61
 ;;^UTILITY(U,$J,358.3,14214,1,8,0)
 ;;=8^Hb-SS Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,14214,2)
 ;;=^330078
 ;;^UTILITY(U,$J,358.3,14215,0)
 ;;=282.63^^87^774^47
 ;;^UTILITY(U,$J,358.3,14215,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14215,1,1,0)
 ;;=1^282.63
 ;;^UTILITY(U,$J,358.3,14215,1,8,0)
 ;;=8^Sickle-cell/Hb-C Dis w/o Crisis
 ;;^UTILITY(U,$J,358.3,14215,2)
 ;;=^330080
 ;;^UTILITY(U,$J,358.3,14216,0)
 ;;=282.64^^87^774^46
 ;;^UTILITY(U,$J,358.3,14216,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14216,1,1,0)
 ;;=1^282.64
 ;;^UTILITY(U,$J,358.3,14216,1,8,0)
 ;;=8^Sickle-cell/Hb-C Dis w/ Crisis
 ;;^UTILITY(U,$J,358.3,14216,2)
 ;;=^329911
 ;;^UTILITY(U,$J,358.3,14217,0)
 ;;=282.68^^87^774^34
 ;;^UTILITY(U,$J,358.3,14217,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14217,1,1,0)
 ;;=1^282.68
 ;;^UTILITY(U,$J,358.3,14217,1,8,0)
 ;;=8^Oth Sickle-cell Dis w/o Crisis
 ;;^UTILITY(U,$J,358.3,14217,2)
 ;;=^329912
 ;;^UTILITY(U,$J,358.3,14218,0)
 ;;=282.69^^87^774^33
 ;;^UTILITY(U,$J,358.3,14218,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14218,1,1,0)
 ;;=1^282.69
 ;;^UTILITY(U,$J,358.3,14218,1,8,0)
 ;;=8^Oth Sickle-cell Dis w/ Crisis
 ;;^UTILITY(U,$J,358.3,14218,2)
 ;;=^330081
 ;;^UTILITY(U,$J,358.3,14219,0)
 ;;=282.7^^87^774^30
 ;;^UTILITY(U,$J,358.3,14219,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14219,1,1,0)
 ;;=1^282.7
 ;;^UTILITY(U,$J,358.3,14219,1,8,0)
 ;;=8^Oth Hemoglobinopathies
 ;;^UTILITY(U,$J,358.3,14219,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,14220,0)
 ;;=282.8^^87^774^36
 ;;^UTILITY(U,$J,358.3,14220,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14220,1,1,0)
 ;;=1^282.8
 ;;^UTILITY(U,$J,358.3,14220,1,8,0)
 ;;=8^Oth Spec Hereditary Hemolytic
 ;;^UTILITY(U,$J,358.3,14220,2)
 ;;=^267984
 ;;^UTILITY(U,$J,358.3,14221,0)
 ;;=283.10^^87^774^27
 ;;^UTILITY(U,$J,358.3,14221,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14221,1,1,0)
 ;;=1^283.10
 ;;^UTILITY(U,$J,358.3,14221,1,8,0)
 ;;=8^Non-autoimmune Hemolytic Anemia
 ;;^UTILITY(U,$J,358.3,14221,2)
 ;;=^294004
 ;;^UTILITY(U,$J,358.3,14222,0)
 ;;=283.11^^87^774^21
 ;;^UTILITY(U,$J,358.3,14222,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14222,1,1,0)
 ;;=1^283.11
 ;;^UTILITY(U,$J,358.3,14222,1,8,0)
 ;;=8^Hemolytic-uremic Syndrome
 ;;^UTILITY(U,$J,358.3,14222,2)
 ;;=^293663
 ;;^UTILITY(U,$J,358.3,14223,0)
 ;;=285.0^^87^774^48
 ;;^UTILITY(U,$J,358.3,14223,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14223,1,1,0)
 ;;=1^285.0
 ;;^UTILITY(U,$J,358.3,14223,1,8,0)
 ;;=8^Sideroblastic Anemia
 ;;^UTILITY(U,$J,358.3,14223,2)
 ;;=^7204
 ;;^UTILITY(U,$J,358.3,14224,0)
 ;;=285.3^^87^774^9
 ;;^UTILITY(U,$J,358.3,14224,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14224,1,1,0)
 ;;=1^285.3
 ;;^UTILITY(U,$J,358.3,14224,1,8,0)
 ;;=8^Antineoplastic Chemo Ind Anemia
 ;;^UTILITY(U,$J,358.3,14224,2)
 ;;=^338232
 ;;^UTILITY(U,$J,358.3,14225,0)
 ;;=285.8^^87^774^35
 ;;^UTILITY(U,$J,358.3,14225,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14225,1,1,0)
 ;;=1^285.8
 ;;^UTILITY(U,$J,358.3,14225,1,8,0)
 ;;=8^Oth Spec Anemia
 ;;^UTILITY(U,$J,358.3,14225,2)
 ;;=^87876
 ;;^UTILITY(U,$J,358.3,14226,0)
 ;;=283.2^^87^774^20
 ;;^UTILITY(U,$J,358.3,14226,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14226,1,1,0)
 ;;=1^283.2
 ;;^UTILITY(U,$J,358.3,14226,1,8,0)
 ;;=8^Hemolytic d/t Hemolysis
 ;;^UTILITY(U,$J,358.3,14226,2)
 ;;=^55770
 ;;^UTILITY(U,$J,358.3,14227,0)
 ;;=286.9^^87^775^11
 ;;^UTILITY(U,$J,358.3,14227,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14227,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,14227,1,8,0)
 ;;=8^Defective Coagulation,Unspec
 ;;^UTILITY(U,$J,358.3,14227,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,14228,0)
 ;;=446.6^^87^775^28
 ;;^UTILITY(U,$J,358.3,14228,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14228,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,14228,1,8,0)
 ;;=8^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,14228,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,14229,0)
 ;;=451.9^^87^775^27
 ;;^UTILITY(U,$J,358.3,14229,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14229,1,1,0)
 ;;=1^451.9
 ;;^UTILITY(U,$J,358.3,14229,1,8,0)
 ;;=8^Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,14229,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,14230,0)
 ;;=287.5^^87^775^25
 ;;^UTILITY(U,$J,358.3,14230,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14230,1,1,0)
 ;;=1^287.5
 ;;^UTILITY(U,$J,358.3,14230,1,8,0)
 ;;=8^Thrombocytopenia Nos
 ;;^UTILITY(U,$J,358.3,14230,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,14231,0)
 ;;=287.1^^87^775^23
 ;;^UTILITY(U,$J,358.3,14231,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14231,1,1,0)
 ;;=1^287.1
 ;;^UTILITY(U,$J,358.3,14231,1,8,0)
 ;;=8^Qualitative Platelet Defects
 ;;^UTILITY(U,$J,358.3,14231,2)
 ;;=^101922
 ;;^UTILITY(U,$J,358.3,14232,0)
 ;;=287.30^^87^775^22
 ;;^UTILITY(U,$J,358.3,14232,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14232,1,1,0)
 ;;=1^287.30
 ;;^UTILITY(U,$J,358.3,14232,1,8,0)
 ;;=8^Primary Thrombocytopenia (ITP)
 ;;^UTILITY(U,$J,358.3,14232,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,14233,0)
 ;;=238.71^^87^775^26
 ;;^UTILITY(U,$J,358.3,14233,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14233,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,14233,1,8,0)
 ;;=8^Thrombocytosis,Essential
 ;;^UTILITY(U,$J,358.3,14233,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,14234,0)
 ;;=286.52^^87^775^2
 ;;^UTILITY(U,$J,358.3,14234,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14234,1,1,0)
 ;;=1^286.52
 ;;^UTILITY(U,$J,358.3,14234,1,8,0)
 ;;=8^Acquired Hemophilia
 ;;^UTILITY(U,$J,358.3,14234,2)
 ;;=^340502
 ;;^UTILITY(U,$J,358.3,14235,0)
 ;;=286.53^^87^775^5
 ;;^UTILITY(U,$J,358.3,14235,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14235,1,1,0)
 ;;=1^286.53
 ;;^UTILITY(U,$J,358.3,14235,1,8,0)
 ;;=8^Antiphospholipid w/ Hemor d/o
 ;;^UTILITY(U,$J,358.3,14235,2)
 ;;=^340503
 ;;^UTILITY(U,$J,358.3,14236,0)
 ;;=286.59^^87^775^16
 ;;^UTILITY(U,$J,358.3,14236,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14236,1,1,0)
 ;;=1^286.59
 ;;^UTILITY(U,$J,358.3,14236,1,8,0)
 ;;=8^Oth Hemor d/o d/t Anticoagulant
 ;;^UTILITY(U,$J,358.3,14236,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,14237,0)
 ;;=286.0^^87^775^9
 ;;^UTILITY(U,$J,358.3,14237,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14237,1,1,0)
 ;;=1^286.0
 ;;^UTILITY(U,$J,358.3,14237,1,8,0)
 ;;=8^Congenital Factor VII Disorder
 ;;^UTILITY(U,$J,358.3,14237,2)
 ;;=^27454
 ;;^UTILITY(U,$J,358.3,14238,0)
 ;;=286.1^^87^775^7
 ;;^UTILITY(U,$J,358.3,14238,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14238,1,1,0)
 ;;=1^286.1
 ;;^UTILITY(U,$J,358.3,14238,1,8,0)
 ;;=8^Cogenital Factor IX Disorder
 ;;^UTILITY(U,$J,358.3,14238,2)
 ;;=^27452
 ;;^UTILITY(U,$J,358.3,14239,0)
 ;;=286.2^^87^775^10
 ;;^UTILITY(U,$J,358.3,14239,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14239,1,1,0)
 ;;=1^286.2
 ;;^UTILITY(U,$J,358.3,14239,1,8,0)
 ;;=8^Congenital Factor XI Deficiency
 ;;^UTILITY(U,$J,358.3,14239,2)
 ;;=^27456
 ;;^UTILITY(U,$J,358.3,14240,0)
 ;;=286.3^^87^775^8
 ;;^UTILITY(U,$J,358.3,14240,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14240,1,1,0)
 ;;=1^286.3
 ;;^UTILITY(U,$J,358.3,14240,1,8,0)
 ;;=8^Congenital Def of Oth Clotting
 ;;^UTILITY(U,$J,358.3,14240,2)
 ;;=^27437
 ;;^UTILITY(U,$J,358.3,14241,0)
 ;;=286.4^^87^775^30
 ;;^UTILITY(U,$J,358.3,14241,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14241,1,1,0)
 ;;=1^286.4
 ;;^UTILITY(U,$J,358.3,14241,1,8,0)
 ;;=8^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,14241,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,14242,0)
 ;;=286.52^^87^775^3
 ;;^UTILITY(U,$J,358.3,14242,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14242,1,1,0)
 ;;=1^286.52
 ;;^UTILITY(U,$J,358.3,14242,1,8,0)
 ;;=8^Acquired Hemophilia
 ;;^UTILITY(U,$J,358.3,14242,2)
 ;;=^340502
 ;;^UTILITY(U,$J,358.3,14243,0)
 ;;=286.53^^87^775^6
 ;;^UTILITY(U,$J,358.3,14243,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14243,1,1,0)
 ;;=1^286.53
 ;;^UTILITY(U,$J,358.3,14243,1,8,0)
 ;;=8^Antiphospholipid w/ Hemor d/o
 ;;^UTILITY(U,$J,358.3,14243,2)
 ;;=^340503
 ;;^UTILITY(U,$J,358.3,14244,0)
 ;;=286.59^^87^775^17
 ;;^UTILITY(U,$J,358.3,14244,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,14244,1,1,0)
 ;;=1^286.59
 ;;^UTILITY(U,$J,358.3,14244,1,8,0)
 ;;=8^Oth Hemor d/o d/t Anticoagulant
 ;;^UTILITY(U,$J,358.3,14244,2)
 ;;=^340504
